Search
SOLACI Congress
HomeCONGRESS

CONGRESS

View Category
Day 4

AVOID: Randomized controlled trial of oxygen therapy in AMI with ST-segment elevation: Air versus oxygen in myocardial infarction

Dion Stub2014-11-20
solaci -
Learn More
Day 4

EVOLVE II TRIAL: SYNERGY everolimus-eluting stent is not inferior to Promus Element

Dean J. Kereiakes2014-11-20
solaci -
Learn More
Day 4

Long-term outcome of a biodegradable polymer compared with durable polymers in drug eluting and conventional stents – Main results of a prospective randomized study

ArticleChristoph A Kaiser2014-11-20
solaci -
Learn More
Day 1

PEGASUS-TIMI 54: Ticagrelor plus ASA in stable patients

This double-blind study included 21162 patients with a history of acute myocardial infarction randomized to ticagrelor 90...
solaci -
Learn More
Day 1

PARTNER to 5 years. TAVR is an effective alternative to surgery in high risk patients

This study included 699 patients with severe aortic stenosis and high surgical risk of whom 348 received...
solaci -
Learn More
Day 1

Improved survival after out-of-hospital cardiac arrest with the use of automated external defibrillators

This study included patients presenting out of hospital cardiac arrest between 2006 and 2012 in The Netherlands...
solaci -
Learn More
Day 1

Coronary flow reserve is associated to adverse events regardless angiographic severity.

This study included 329 consecutive patients derived to coronary angiography based on myocardial perfusion tests or PET...
solaci -
Learn More
Day 1

ITALIC PLUS: 6 months of double antiaggregation for no less than 24 months

Article This multicenter study included patients receiving the second generation stent XIENCE V (Abbott Vascular) randomized to 6...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dr. Juan Manuel Pérez - 0
Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

Dr. Omar Tupayachi - 0
The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

How real are the adverse effects of statins? Evidence from randomized clinical trials

Dr. Juan Manuel Pérez - 0
The safety of statins continues to be a subject of debate, partly due to the extensive list of adverse effects included in prescribing information,...

Institutional News

Fellow’s Corner 2026 – Submit Your Clinical Case

solaci - 0
Share your experience. Learn from experts. Grow as an interventional cardiologist. The Latin American Society of Interventional Cardiology (SOLACI) is relaunching this year the Fellow’s...

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

solaci - 0
The webinar “Cardiovascular Risk Factors in Women,” held on January 27, 2026, via the Zoom platform, is now available for viewing on SOLACI’s YouTube...

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

solaci - 0
The SOLACI–CACI Technical Training in Hemodynamics and Interventional Cardioangiology is an academic program designed for the initial training and professional development of non-physician healthcare...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy